Asia Pacific Deep Brain Stimulation Devices Market Size & Outlook
Asia Pacific deep brain stimulation devices market, 2018-2030 (US$M)
Related Markets
Asia Pacific deep brain stimulation devices market highlights
- The Asia Pacific deep brain stimulation devices market generated a revenue of USD 193.4 million in 2024.
- The market is expected to grow at a CAGR of 11.4% from 2025 to 2030.
- In terms of segment, dystonia was the largest revenue generating application in 2024.
- Epilepsy is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, Thailand is expected to register the highest CAGR from 2025 to 2030.
Asia Pacific data book summary
| Market revenue in 2024 | USD 193.4 million |
| Market revenue in 2030 | USD 366.5 million |
| Growth rate | 11.4% (CAGR from 2025 to 2030) |
| Largest segment | Dystonia |
| Fastest growing segment | Epilepsy |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pain Management, Epilepsy, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinsons Disease, Depression, Dystonia |
| Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 13.8% of the global deep brain stimulation devices market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 366.5 million by 2030.
Dystonia was the largest segment with a revenue share of 72.34% in 2024. Horizon Databook has segmented the Asia Pacific deep brain stimulation devices market based on pain management, epilepsy, essential tremor, obsessive compulsive disorder (ocd), parkinsons disease, depression, dystonia covering the revenue growth of each sub-segment from 2018 to 2030.
The Asia Pacific deep brain stimulation devices market is anticipated to exhibit lucrative growth during the forecast period. Rising prevalence of neurodegenerative and psychiatric disorders coupled with unmet need for effective & long-term treatment solutions is expected to present significant growth opportunities for deep brain stimulation devices in this region.
Moreover, high R&D investments by global market players owing to their low-cost structure are among the key drivers of the market in Asia Pacific region. Rising awareness about neurological disease treatment options and improvements in clinical development framework of emerging economies are expected to drive the market growth.
Furthermore, establishment of organizations such as the Asia-Pacific Centre for Neuromodulation (APCN), which is founded for conducting research and promoting awareness about associated benefits of deep brain stimulation, is anticipated to boost market growth.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Deep Brain Stimulation Devices Market Scope
Deep Brain Stimulation Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific deep brain stimulation devices market size, by country, 2018-2030 (US$M)
Asia Pacific Deep Brain Stimulation Devices Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
